IL117988A0 - A new combination of an inhibitor and an antagonist - Google Patents

A new combination of an inhibitor and an antagonist

Info

Publication number
IL117988A0
IL117988A0 IL11798896A IL11798896A IL117988A0 IL 117988 A0 IL117988 A0 IL 117988A0 IL 11798896 A IL11798896 A IL 11798896A IL 11798896 A IL11798896 A IL 11798896A IL 117988 A0 IL117988 A0 IL 117988A0
Authority
IL
Israel
Prior art keywords
antagonist
inhibitor
new combination
new
combination
Prior art date
Application number
IL11798896A
Other languages
English (en)
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of IL117988A0 publication Critical patent/IL117988A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrane Compounds (AREA)
IL11798896A 1995-04-27 1996-04-21 A new combination of an inhibitor and an antagonist IL117988A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9501567A SE9501567D0 (sv) 1995-04-27 1995-04-27 A new combination

Publications (1)

Publication Number Publication Date
IL117988A0 true IL117988A0 (en) 1996-08-04

Family

ID=20398119

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11798896A IL117988A0 (en) 1995-04-27 1996-04-21 A new combination of an inhibitor and an antagonist

Country Status (29)

Country Link
US (5) US5962514A (cs)
EP (1) EP0822813B1 (cs)
JP (1) JPH11504037A (cs)
KR (1) KR100419810B1 (cs)
CN (1) CN1102386C (cs)
AR (1) AR002990A1 (cs)
AT (1) ATE216579T1 (cs)
BR (1) BR9608252A (cs)
CA (1) CA2218181A1 (cs)
CZ (1) CZ335697A3 (cs)
DE (1) DE69620878T2 (cs)
DK (1) DK0822813T3 (cs)
EE (1) EE03553B1 (cs)
ES (1) ES2175089T3 (cs)
HU (1) HUP9801946A3 (cs)
IL (1) IL117988A0 (cs)
IS (1) IS1821B (cs)
NO (1) NO317057B1 (cs)
NZ (1) NZ306602A (cs)
PL (1) PL183997B1 (cs)
PT (1) PT822813E (cs)
RU (1) RU2183955C2 (cs)
SE (1) SE9501567D0 (cs)
SK (1) SK282060B6 (cs)
TR (1) TR199701254T1 (cs)
TW (1) TW458777B (cs)
WO (1) WO1996033710A1 (cs)
YU (1) YU25696A (cs)
ZA (1) ZA962982B (cs)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9501567D0 (sv) * 1995-04-27 1995-04-27 Astra Ab A new combination
SE9703374D0 (sv) * 1997-09-18 1997-09-18 Astra Ab A new combination
AU4100699A (en) * 1998-05-28 1999-12-13 Sepracor, Inc. Compositions and methods employing r(-) fluoxetine and other active ingredients
SE9803158D0 (sv) * 1998-09-16 1998-09-16 Astra Ab A new composition
SE9803156D0 (sv) * 1998-09-16 1998-09-16 Astra Ab A new composition
SE9803157D0 (sv) * 1998-09-16 1998-09-16 Astra Ab A new composition
SE9803155D0 (sv) * 1998-09-16 1998-09-16 Astra Ab A new composition
AR021155A1 (es) * 1999-07-08 2002-06-12 Lundbeck & Co As H Tratamiento de desordenes neuroticos
UA77650C2 (en) * 1999-12-06 2007-01-15 Lundbeck & Co As H Use of serotonin reuptake inhibitor in combination with deramcyclane
US6331233B1 (en) 2000-02-02 2001-12-18 Honeywell International Inc. Tantalum sputtering target with fine grains and uniform texture and method of manufacture
WO2002030405A2 (en) 2000-10-13 2002-04-18 Neurosearch A/S Treatment of affective disorders by the combined action of a nicotinic receptor agonist and a monoaminergic substance
US20030166554A1 (en) * 2001-01-16 2003-09-04 Genset, S.A. Treatment of CNS disorders using D-amino acid oxidase and D-aspartate oxidase antagonists
US20030185754A1 (en) * 2001-01-16 2003-10-02 Genset, S.A. Treatment of CNS disorders using D-amino acid oxidase and D-aspartate oxidase antagonists
UA82828C2 (en) * 2001-05-01 2008-05-26 Lundbeck & Co As H The use of enantiomeric pure escitalopram for treatment of depression
US7034059B2 (en) 2001-07-02 2006-04-25 Sepracor Inc. Methods of using norfluoxetine
US6855735B2 (en) 2002-03-20 2005-02-15 Temple University Of The Commonwealth System Of Higher Education Ketamine treatment of restless legs syndrome
EP1534258A2 (en) * 2002-08-15 2005-06-01 Wyeth AGONISM OF THE 5HT 2a RECEPTOR FOR TREATMENT OF THERMOREGULATORY DYSFUNCTION
US20050032873A1 (en) * 2003-07-30 2005-02-10 Wyeth 3-Amino chroman and 2-amino tetralin derivatives
US7695601B2 (en) * 2006-05-09 2010-04-13 The United States Of America As Represented By The Secretary Of The Army Electrochemical test apparatus and method for its use
US20080033050A1 (en) 2006-08-04 2008-02-07 Richards Patricia Allison Tewe Method of treating thermoregulatory disfunction with paroxetine
US20160154928A1 (en) * 2013-07-12 2016-06-02 Immuneering Corporation Systems, methods, and environment for automated review of genomic data to identify downregulated and/or upregulated gene expression indicative of a disease or condition
US11491136B2 (en) * 2017-02-14 2022-11-08 Research Triangle Institute Proline-based neuropeptide FF receptor modulators

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4698342A (en) * 1985-07-16 1987-10-06 Serotonin Industries Of Charleston Method and compositions for controlling pain, depression and sedation
US5420151A (en) * 1989-12-22 1995-05-30 Aktiebolaget Astra Chroman derivatives
US5616610A (en) * 1989-12-22 1997-04-01 Astra Aktiebolag (R)-5-carbamoyl-8-fluoro-3-N,N-disubstituted-amino-3,4-dihydro-2H-1-benzopyrans
SE9501567D0 (sv) * 1995-04-27 1995-04-27 Astra Ab A new combination

Also Published As

Publication number Publication date
TR199701254T1 (xx) 1998-02-21
WO1996033710A1 (en) 1996-10-31
PL183997B1 (pl) 2002-08-30
EE03553B1 (et) 2001-12-17
ES2175089T3 (es) 2002-11-16
SK142997A3 (en) 1998-12-02
RU2183955C2 (ru) 2002-06-27
TW458777B (en) 2001-10-11
US5962514A (en) 1999-10-05
DE69620878D1 (de) 2002-05-29
EP0822813A1 (en) 1998-02-11
ATE216579T1 (de) 2002-05-15
PL323083A1 (en) 1998-03-02
HUP9801946A2 (hu) 2000-05-28
NO974921D0 (no) 1997-10-24
CA2218181A1 (en) 1996-10-31
IS4585A (is) 1997-10-09
US6169098B1 (en) 2001-01-02
US6184219B1 (en) 2001-02-06
YU25696A (sh) 1999-06-15
KR100419810B1 (ko) 2004-04-21
EP0822813B1 (en) 2002-04-24
NO974921L (no) 1997-12-18
SK282060B6 (sk) 2001-10-08
NO317057B1 (no) 2004-08-02
US6172105B1 (en) 2001-01-09
AU5520296A (en) 1996-11-18
IS1821B (is) 2002-08-27
AR002990A1 (es) 1998-05-27
DE69620878T2 (de) 2002-11-14
EE9700245A (et) 1998-04-15
PT822813E (pt) 2002-10-31
NZ306602A (en) 1999-04-29
AU696356B2 (en) 1998-09-10
CZ335697A3 (cs) 1998-06-17
KR19990008068A (ko) 1999-01-25
US6184218B1 (en) 2001-02-06
CN1102386C (zh) 2003-03-05
DK0822813T3 (da) 2002-07-29
ZA962982B (en) 1996-10-28
BR9608252A (pt) 1999-05-04
CN1187768A (zh) 1998-07-15
JPH11504037A (ja) 1999-04-06
HUP9801946A3 (en) 2000-12-28
SE9501567D0 (sv) 1995-04-27
HK1002853A1 (en) 1998-09-25

Similar Documents

Publication Publication Date Title
IL117988A0 (en) A new combination of an inhibitor and an antagonist
PL327569A1 (en) Promedications of thrombosin inhibitors
GB2300566B (en) A combination capable of forming an odour barrier and methods of use
PL322549A1 (en) Inhibitors of proteinous farnesiltransferase
HUP9900666A3 (en) Phosphodiesterase inhibitor phenanthridines derivatives and use thereof
AU4786496A (en) New forms of paroxetin hydrochloride
ZA964754B (en) Ketoheterocyclic inhibitors of factor xa
HRP960075B1 (en) New thrombin inhibitors
IL122813A0 (en) Thrombin inhibitors their preparation and use
IL122266A0 (en) Inhibitors of phospholipase A2
GB9526560D0 (en) Use of 2-Amino-Heterocycles
IL123653A0 (en) Chemokine inhibitor
GB2285983B (en) A method of inhibiting polymerization of vinyl compound and polymerization inhibitor used therein
IL123320A0 (en) Detection of hypoprathyroidism
ZA96725B (en) Use of phenyclyclohexylcarboxamides
HUP9904617A3 (en) Secondary cataract inhibitor
AU9640698A (en) Pharmaceutical combination of a cyclooxigenase-2 inhibitor and acetaminophen or an opiate
IL118574A0 (en) Methods of inhibiting melanoma
GB9724377D0 (en) Accumulator circuit and method of use thereof
IL114804A0 (en) A ceiling construction and method for the construction of same
ZA987810B (en) A combination of a selective 5HT1A antagonist and a selective h5-HT1B antagonist or partial agonist
DE69523450D1 (en) Inhibitor
EP0821961A4 (en) INHIBITOR OF NEOVASCULARIZATION
EP0841910A4 (en) INHIBITION OF A TRANSACYLASE INDEPENDENT OF COENZYME A (CoA) AND APOPTOSIS
GB9700233D0 (en) Use of glycosidase inhibitors

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees